118 related articles for article (PubMed ID: 6025389)
1. Testosterone-induced activation of fibrinolysis in carcinoma of the prostate.
Rosswick RP
Br J Urol; 1967 Apr; 39(2):143-6. PubMed ID: 6025389
[No Abstract] [Full Text] [Related]
2. Experiences with F-32 in advanced carcinoma of the prostate.
Corwin SH; Malament M; Small M; Strauss HD
J Urol; 1970 Nov; 104(5):745-8. PubMed ID: 5486859
[No Abstract] [Full Text] [Related]
3. Phosphorus 32 for intractable pain in carcinoma of the prostate.
Johnson DE; Haynie TP
Tex Med; 1971 Mar; 67(3):57-9. PubMed ID: 4103609
[No Abstract] [Full Text] [Related]
4. The use of radioactive phosphorus to treat bone pain in metastatic carcinoma of the prostate.
Morales A; Burr RC; Bruce AW
Can Med Assoc J; 1970 Aug; 103(4):372-3. PubMed ID: 5447717
[No Abstract] [Full Text] [Related]
5. [Successful relief of severe pain from bone metastases of carcinoma of the prostate by the treatment with P32].
Nakaarai K; Tokizane M; Okuda N; Ito S
Hinyokika Kiyo; 1966 Dec; 12(12):1429-34. PubMed ID: 4167082
[No Abstract] [Full Text] [Related]
6. Regression of prostatic cancer metastasis by high doses of diethylstilbestrol diphosphate.
Susan LP; Roth RB; Adkins WC
Urology; 1976 Jun; 7(6):598-601. PubMed ID: 936380
[TBL] [Abstract][Full Text] [Related]
7. Generalized bleeding following the treatment of prostatic carcinoma with testosterone and radioactive phosphorus.
Ellman L
J Urol; 1973 Sep; 110(3):331-2. PubMed ID: 4725740
[No Abstract] [Full Text] [Related]
8. RADIOACTIVE PHOSPHORUS TREATMENT OF BONE-METASTATIC CARCINOMA OF THE PROSTATE.
SMART JG
Lancet; 1964 Oct; 2(7365):882-3. PubMed ID: 14197184
[No Abstract] [Full Text] [Related]
9. Androgen therapy in advanced carcinoma of the prostate.
Morales A; Connolly JG; Bruce AW
Can Med Assoc J; 1971 Jul; 105(1):71-2. PubMed ID: 5088479
[No Abstract] [Full Text] [Related]
10. Radioactive phosphorus in the treatment of metastasis to bone from carcinoma of the prostate.
Morin LJ; Stevens JC
J Urol; 1967 Jan; 97(1):130-2. PubMed ID: 4163114
[No Abstract] [Full Text] [Related]
11. [Combination of P32 and testosterone in the treatment of pain due to osseous metastasis of prostate neoplasms].
García de la Peña E; Sánchez Martín JA; Linazasoro JM; Cifuentes Delatte L
Rev Clin Esp; 1974 Sep; 134(6):527-34. PubMed ID: 4141512
[No Abstract] [Full Text] [Related]
12. Proceedings: Testosterone potentiated radiophosphorus therapy of osseous metastases in prostatic cancer.
Edland RW
Am J Roentgenol Radium Ther Nucl Med; 1974 Mar; 120(3):678-83. PubMed ID: 4816818
[No Abstract] [Full Text] [Related]
13. Palliative treatment of osseous metastases from carcinoma of the breast and carcinoma of the prostate with radioactive phosphorus and testosterone.
Walton RJ
J Can Assoc Radiol; 1965 Dec; 16(4):213-6. PubMed ID: 4159432
[No Abstract] [Full Text] [Related]
14. Testosterone potentiated 32P therapy in prostatic carcinoma.
Donati RM; Ellis H; Gallagher NI
Cancer; 1966 Aug; 19(8):1088-90. PubMed ID: 4161770
[No Abstract] [Full Text] [Related]
15. Bone marrow metastases from prostatic cancer-marked cytolytic effect after only a few days of treatment with diethylstilbestrol.
Bjøorneklett A; Stavem P; Ly B; Egeberg O
Scand J Haematol; 1976 Sep; 17(3):227-30. PubMed ID: 968453
[TBL] [Abstract][Full Text] [Related]
16. Editorial: Stilboestrol: use and abuse in prostatic disease.
N Z Med J; 1974 Aug; 80(521):113. PubMed ID: 4529401
[No Abstract] [Full Text] [Related]
17. The treatment of bone metastases with parathormone followed by radiophosphorus.
Tong EC; Rubenfeld S
Am J Roentgenol Radium Ther Nucl Med; 1967 Feb; 99(2):422-34. PubMed ID: 6020191
[No Abstract] [Full Text] [Related]
18. Radiophosphorous (P32) treatment in carcinoma of the breast and prostate: report of 39 cases.
Miller AD
J Am Osteopath Assoc; 1974 Nov; 74(3):217-22. PubMed ID: 4139177
[No Abstract] [Full Text] [Related]
19. THE USE OF P32 IN THE TREATMENT OF SEVERE PAIN FROM BONE METASTASES OF CARCINOMA OF THE PROSTATE.
SMART JG
Br J Urol; 1965 Apr; 37():139-47. PubMed ID: 14282079
[No Abstract] [Full Text] [Related]
20. Paraplegia and paraparesis due to prostatic cancer. Use of intravenous diethylstilbestrol diphosphate.
Hawtrey CE; Welch MJ; Schmidt JD; Culp DA; Flocks RH
Urology; 1974 Oct; 4(4):431-4. PubMed ID: 4423432
[No Abstract] [Full Text] [Related]
[Next] [New Search]
